A phase III trial conducted by SWOG S1826 has revealed that the immune checkpoint inhibitor nivolumab (Opdivo) is more effective than brentuximab vedotin (Adcetris) in reducing disease progression or death in newly diagnosed adults and adolescents with advanced-stage classical Hodgkin lymphoma (cHL). Research Findings The trial involved over 976 patients with newly diagnosed stage III-IV
Former UK Prime Minister Boris Johnson has been warned that he could lose UK public funding for legal advice if he tries to “frustrate or undermine” the government’s position on the COVID inquiry. Cabinet Office lawyers have informed Johnson that public money would “cease to be available” if he breaks conditions such as releasing evidence